Harvard Bioscience (HBIO) Receivables (2010 - 2026)
Harvard Bioscience (HBIO) reported Receivables of $14.6 million for Q1 2026, up 8.11% year-over-year from $13.5 million in Q1 2025, and down 9.17% on a QoQ basis from $16.0 million in Q4 2025.
Harvard Bioscience (HBIO) has 17 years of Receivables data on file, last reported at $14.6 million in Q1 2026.
- Quarterly Receivables rose 8.11% year-over-year to $14.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $14.6 million (up 8.11% YoY) and the FY2025 annual result came in at $16.0 million, up 7.92% from the prior year.
- Receivables retreated to $14.6 million in Q1 2026 per HBIO's latest filing, from $16.0 million in the prior quarter.
- Across five years, Receivables topped out at $20.3 million in Q1 2022 and bottomed at $11.9 million in Q2 2025.
- The 5-year median for Receivables is $15.0 million (2022), against an average of $15.2 million.
- The widest annual swing landed in 2022, when Receivables climbed 18.74%; it then retreated 26.13% in 2024.
- Tracing HBIO's Receivables over 5 years: stood at $16.7 million in 2022, then fell by 3.63% to $16.1 million in 2023, then retreated by 7.66% to $14.9 million in 2024, then climbed by 7.92% to $16.0 million in 2025, then retreated by 9.17% to $14.6 million in 2026.
- Per Business Quant, the three latest HBIO Receivables figures stand at $14.6 million (Q1 2026), $16.0 million (Q4 2025), and $12.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | 1.62 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | 2.21 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 1.05 Bn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | 701.00 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | 1.18 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 807.10 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | 1.13 Bn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | 1.68 Bn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | 846.13 Mn |
| 10 | Harvard Bioscience | 25.38 Mn | 18.29 Mn | 12.24 Mn | 14.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.57 Mn |
| Dec 31, 2025 | 16.04 Mn |
| Sep 30, 2025 | 12.11 Mn |
| Jun 30, 2025 | 11.94 Mn |
| Mar 31, 2025 | 13.48 Mn |
| Dec 31, 2024 | 14.87 Mn |
| Sep 30, 2024 | 12.83 Mn |
| Jun 30, 2024 | 12.49 Mn |
| Mar 31, 2024 | 15.31 Mn |
| Dec 31, 2023 | 16.10 Mn |
| Sep 30, 2023 | 14.98 Mn |
| Jun 30, 2023 | 16.90 Mn |
| Mar 31, 2023 | 17.74 Mn |
| Dec 31, 2022 | 16.71 Mn |
| Sep 30, 2022 | 15.02 Mn |
| Jun 30, 2022 | 17.85 Mn |
| Mar 31, 2022 | 20.27 Mn |
| Dec 31, 2021 | 21.83 Mn |
| Sep 30, 2021 | 18.34 Mn |
| Jun 30, 2021 | 17.39 Mn |
| Mar 31, 2021 | 17.07 Mn |
| Dec 31, 2020 | 17.77 Mn |
| Sep 30, 2020 | 13.88 Mn |
| Jun 30, 2020 | 14.71 Mn |
| Mar 31, 2020 | 15.43 Mn |
| Dec 31, 2019 | 20.70 Mn |
| Sep 30, 2019 | 17.09 Mn |
| Jun 30, 2019 | 18.39 Mn |
| Mar 31, 2019 | 18.79 Mn |
| Dec 31, 2018 | 21.46 Mn |
| Sep 30, 2018 | 17.88 Mn |
| Jun 30, 2018 | 19.59 Mn |
| Mar 31, 2018 | 18.96 Mn |
| Dec 31, 2017 | 13.38 Mn |
| Sep 30, 2017 | 15.27 Mn |
| Jun 30, 2017 | 15.98 Mn |
| Mar 31, 2017 | 15.48 Mn |
| Dec 31, 2016 | 15.75 Mn |
| Sep 30, 2016 | 15.12 Mn |
| Jun 30, 2016 | 16.35 Mn |
| Mar 31, 2016 | 18.02 Mn |
| Dec 31, 2015 | 17.55 Mn |
| Sep 30, 2015 | 15.59 Mn |
| Jun 30, 2015 | 18.54 Mn |
| Mar 31, 2015 | 16.02 Mn |
| Dec 31, 2014 | 16.14 Mn |
| Sep 30, 2014 | 14.28 Mn |
| Jun 30, 2014 | 14.31 Mn |
| Mar 31, 2014 | 14.32 Mn |
| Dec 31, 2013 | 13.88 Mn |
| Sep 30, 2013 | 13.36 Mn |
| Jun 30, 2013 | 13.83 Mn |
| Mar 31, 2013 | 14.19 Mn |
| Dec 31, 2012 | 14.36 Mn |
| Sep 30, 2012 | 13.60 Mn |
| Jun 30, 2012 | 15.07 Mn |
| Mar 31, 2012 | 16.17 Mn |
| Dec 31, 2011 | 15.08 Mn |
| Sep 30, 2011 | 13.62 Mn |
| Jun 30, 2011 | 14.46 Mn |
| Dec 31, 2010 | 15.44 Mn |